Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$860 Buy
45
+29
+181% +$635 ﹤0.01% 2504
2024
Q4
$381 Hold
16
﹤0.01% 2675
2024
Q3
$448 Hold
16
﹤0.01% 2699
2024
Q2
$418 Hold
16
﹤0.01% 2664
2024
Q1
$350 Hold
16
﹤0.01% 2554
2023
Q4
$372 Hold
16
﹤0.01% 2609
2023
Q3
$316 Hold
16
﹤0.01% 2601
2023
Q2
$363 Hold
16
﹤0.01% 2569
2023
Q1
$314 Hold
16
﹤0.01% 2673
2022
Q4
$275 Buy
+16
New +$284 ﹤0.01% 2693

Other funds holding RXO

Lindbrook Capital's RXO Position: Q1 2025 in Review

Lindbrook Capital increased its RXO (RXO) stake by 181% in Q1 2025, buying an estimated $635 and bringing the position to 45 shares worth $860. The position accounts for ﹤0.01% of the portfolio, ranked #2504.

Lindbrook Capital first reported a position in RXO in Q4 2022 and has held it in 10 quarters since. 258 funds tracked by Wall St. Rank hold RXO as of Q1 2025.

  • Lindbrook Capital held 45 shares of RXO worth $860 as of Q1 2025.
  • Lindbrook Capital bought 29 RXO shares in Q1 2025, an estimated $635.
  • RXO made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2504 holding.
  • Lindbrook Capital first reported a position in RXO in Q4 2022 and has held it in 10 quarters since.
  • 258 funds tracked by Wall St. Rank held RXO as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.